TranS1 Inc. Schedules Third Quarter 2007 Earnings Release and Conference Call for Thursday November 8th, 2007


WILMINGTON, N.C., Nov. 2, 2007 (PRIME NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release third quarter 2007 financial results after market close on Thursday November 8th, 2007. Rick Randall, President and Chief Executive Officer of TranS1, and Mike Luetkemeyer, Chief Financial Officer, will host a conference call starting at 4:30 pm EST on the same day. The call will be concurrently webcast. Because TranS1 is still within the post-IPO quiet period, the company will not have a question and answer session following the presentation, but plans to have question and answer sessions on future calls.

To listen to the conference call on your telephone, please dial 877-591-4958 for domestic callers and 719-325-4909 for international callers approximately ten minutes prior to the start time. To access the live audio broadcast or the subsequent archived recording, visit the TranS1 Web site at www.trans1.com under the investor relations section.

Schedule this webcast into MS-Outlook calendar (click open when prompted): http://apps.shareholder.com/PNWOutlook/t.aspx?m=28309&k=51068624

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary minimally invasive surgical approach to treat degenerative disc disease affecting the lower lumbar region of the spine. TranS1 currently markets two single-level fusion products -- the AxiaLIF(r) and the AxiaLIF 360:o(tm) in the U.S. and Europe. In addition the company currently markets a two-level fusion product -- the AxiaLIF 2L(tm) in Europe. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.



            

Contact Data